Chuck Carlson
The DRIP Investor
J. Royden Ward
Cabot Benjamin Graham Value Letter
John Reese
Validea
Jim Stack
InvesTech Market Analyst

iShares Residential: Rental gains


Bookmark and Share
by Doug Fabian, editor Making Money Alert

With residential real estate showing signs of a budding recovery in certain markets, let's look at one of my favorite funds in the sector, iShares FTSE NAREIT Residential Plus Capped Index ETF (REZ).

REZ offers a way to invest in the recovery of the real estate market. One distinctive characteristic of REZ, compared with many other funds, is that a big chunk of its holdings include apartments.

In fact, nearly half of REZ's holdings feature apartments, 45.05%. Other sizable portions of the fund feature self storage, 16.9%, and health-care real estate, 36.12%. With home prices in many markets still on the decline, sectors such as apartments and self storage usually do well.

The health-care industry typically is fairly stable, regardless of the current economic state of the country.

The fund specifically seeks investment results that correspond generally to the price yield performance, before fees and expenses, of the FTSE NAREIT All Residential Capped Index.

According to the National Apartment Association, renter-occupied households account for 30.6% of all U.S. households and generate more than $325 billion in annual rental revenues.

With the current spread between mortgage prices and rental rates, many observers consider rental units to be more affordable than buying homes.

Furthermore, Default Research, Inc. expects 1.5 million homeowners to lose their houses to foreclosure annually for the next three years. As a result, many apartment complexes around the country are filling up, and demand for apartments still is strong.

REZ's top five holdings and their weights in the fund, as of March 13, were: Equity Residential, 11.48%; Public Storage, 10.86%; HCP Inc., 10.64%; Ventas Inc., 10.57%; and AvalonBay Communities Inc., 4.57%. At year-end 2011, the fund's one-year performance reached 15.85%, while its three-year gain hit 22.74%.

Learn more about this financial newsletter at Doug Fabian's Making Money Alert.

Related articles:

Advertisement
Banner
News Flash

Building assets with Loews
by Adrian Day, editor Global Analyst

We continue to recommend Loews Corp. (L) as an asset play in the U.S.; it is a holding company run by conservative long-term value investors.


Read more...

 

Charged up over Visa
by Leo Fasciocco, editor Ticker Tape Digest

With solid earnings growth coming for the next several quarters, we see Visa Inc. (V) as a good stock to accumulate in anticipation of a breakout. It is currently an institutional favorite based on its steady earnings growth record.


Read more...


   

William Blair: Small cap risk & reward
by Walter Frank, editor MoneyLetter

With 44% of net assets in micro-cap and another 44% in small cap fare, William Blair Small Cap Growth (WBSNX) truly lands at the tinest end of the small cap fund spectrum. That in itself courts more risk than the typical small-cap growth fund.


Read more...

 

Air and auto parts: Rebound buys
by Richard Moroney, editor Upside Stocks

Here, we profile two are attractive rebound plays -- Penske Automotive (PAG) and Triumph (TGI). Both seem capable of attracting investors’ attention and rallying in the year ahead.


Read more...

 

Fidelity: International buys
by Jim Lowell, editor Fidelity Investor

I continue to think the best way to pursue foreign stock opportunities is through managers with longstanding expertise in the foreign stock arena. Here's a look at four of our buy-rated international funds.


Read more...

 

Parexel: One-stop shop in clinical trials
by Mike Cintolo, editor Cabot Top Ten Trader

Parexel International (PRXL) has a great niche in the pharmaceutical industry. Its main service is outsourcing medical research and clinical trials of candidate drugs. Its one-stop-shopping approach to drug development and trials lets Parexel take over the work of an entire division, saving clients enormous amounts of expense.


Read more...

 

Cisco: 'Plenty of room for growth'
by Brian Hicks, editor The Wealth Advisory

CEO John Chambers is making us look good; it is now nine consecutive quarters that Cisco Systems (CSCO) has beaten analysts' earnings estimates.


Read more...

 

Strong growth at value prices
by Stephen Quickel, editor US Investment Report

In selecting new stocks for the Recommended List we aim for leaders in top growth sectors that we think can generate price gains of at least 20%. Here's a look at 5 'buys'.


Read more...

 

Military matters: Top picks in defense
by Jim Powell, editor Global Changes & Opportunities

I continue to recommend leading U.S. defense stocks that have been greatly oversold by investors who are worried about deep cutbacks. Although some expensive “big iron” contracts will be cancelled, I believe many new high tech orders will more than make up for their loss.


Read more...

 

StoneMor: Timely buy in untimely market
by Steve Mauzy, contributing editor Daily Profit

Thanks to baby boomers hitting their golden years en masse, annual deaths in the United States are expected to rise to 3.2 million in 2030 from 2.6 million in 2010. For income-and-yield investors, there's really only one choice in the cemetery sector -- StoneMor Partners (STON), which yields over 9%.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary